US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

SYNAPTOGENIX, INC.

3.58

-0.7200-16.74%

Post-market: 3.970.3900+10.89%19:50 EDT

Volume:264.61K

Turnover:963.04K

Market Cap:4.98M

PE:-0.36

High:4.28

Open:4.25

Low:3.25

Close:4.30

Loading ...

Overview Company News Filings

AI altcoins become the new favorite of listed companies? Some go all in, others test the waters

BRIEF-Synaptogenix Says On June 8, Alan Tuchman Resigned As CEO And Director Of Co

Synaptogenix Inc: on June 8, Alan J. Tuchman Resigned as CEO and Director of Co

THOMSON REUTERS

Synaptogenix Inc: Tuchman to Serve as Chief Medical Officer of Co

THOMSON REUTERS

Synaptogenix Inc: on June 6, Joshua Silverman Appointed as Executive Chairman of Co’s Board of Directors

THOMSON REUTERS

Synaptogenix Inc - Series D Preferred Stock Conversion Price Set at $3.00 per Share

THOMSON REUTERS

Synaptogenix Inc - Plans Initial $10 Mln Tao Acquisition, Targets $100 Mln in Tao Token Acquisitions

THOMSON REUTERS

Synaptogenix: Launch of Differentiated Cryptocurrency Treasury Strategy Focused Exclusively on AI Crypto Token "Tao"

THOMSON REUTERS

Synaptogenix Inc - Enters $5.5 Mln Financing Agreement

THOMSON REUTERS

Synaptogenix Inc. Secures $5.5 Million in Equity Investment Through Sale of Series D Convertible Preferred Stock

Press Release: Synaptogenix Appoints Crypto Expert to Lead Digital Asset Treasury Strategy Focused Exclusively on Top-Valued AI Token

Synaptogenix Q1 EPS $0.04 Up From $(0.41) YoY

Psychedelic: Clearmind completes clinical site initiations for AUD trial

Psychedelic: Exclusive talk with biotech company Clearmind Medicine

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SNPX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SNPX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNPX\",,,,,undefined,":{"symbol":"SNPX","market":"US","secType":"STK","nameCN":"SYNAPTOGENIX, INC.","latestPrice":3.58,"timestamp":1750708800000,"preClose":4.3,"halted":0,"volume":264609,"hourTrading":{"tag":"盘后","latestPrice":3.97,"preClose":3.58,"latestTime":"19:50 EDT","volume":1331,"amount":5094.53,"timestamp":1750722624460},"delay":0,"floatShares":1380701,"shares":1389815,"eps":-9.900128,"marketStatus":"Not Yet Opened","change":-0.72,"latestTime":"06-23 16:00:00 EDT","open":4.25,"high":4.28,"low":3.25,"amount":963043.6087511999,"amplitude":0.239535,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-9.900128,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750752000000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":4.3,"preHourTrading":{"tag":"盘前","latestPrice":4.24,"preClose":4.3,"latestTime":"09:29 EDT","volume":5750,"amount":23785.746125,"timestamp":1750685366043},"postHourTrading":{"tag":"盘后","latestPrice":3.97,"preClose":3.58,"latestTime":"19:50 EDT","volume":1331,"amount":5094.53,"timestamp":1750722624460},"volumeRatio":1.047483},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNPX\",,,,,undefined,":{"symbol":"SNPX","floatShares":1380701,"roa":"-17.29%","roe":"-83.05%","lyrEps":-10.990077,"volumeRatio":1.047483,"shares":1389815,"dividePrice":0,"high":4.28,"amplitude":0.239535,"preClose":4.3,"low":3.25,"week52Low":1.84,"pbRate":"0.96","week52High":5.52,"institutionHeld":0,"latestPrice":3.58,"eps":-9.900128,"divideRate":0,"volume":264609,"delay":0,"ttmEps":-9.900128,"open":4.25,"prevYearClose":3.47,"prevWeekClose":4.3,"prevMonthClose":2.515,"prevQuarterClose":2.42,"fiveDayClose":3.71,"twentyDayClose":2.2099,"sixtyDayClose":2.66},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNPX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543570553","title":"AI altcoins become the new favorite of listed companies? Some go all in, others test the waters","url":"https://stock-news.laohu8.com/highlight/detail?id=2543570553","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543570553?lang=en_us&edition=fundamental","pubTime":"2025-06-13 15:00","pubTimestamp":1749798000,"startTime":"0","endTime":"0","summary":"To answer this question, let’s examine which companies are already backing these AI-related tokens and explore the strategies and risks behind their actions.1. Interactive Strength : Buying $FET, a Fitness + AI LeapInteractive Strength is a Nasdaq-listed company primarily engaged in selling professional fitness equipment alongside digital fitness services under its two brands: CLMBR and FORME. Put simply, the company generates revenue by selling hardware products like fitness mirrors and climbing machines, complemented by associated fitness classes and a digital platform.Recent data shows a market cap of approximately $8.4 million for the company. On June 11, it announced plans to allocate $500 million to purchase $FET tokens as part of its cryptocurrency treasury strategy. The company intends to utilize these tokens to support its AI-driven fitness products. CEO Ward explained that choosing FET over more widely held assets like Bitcoin reflects the company's plans to integrate Fetch.a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info/en/news/58584","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_highlight","symbols":["SOL.USD.HKCC","BK4585","BTC.USD.CC","TON.USD.HKCC","TON.USD.CC","OBLG","BK4588","BTC.USD.HKCC","BK4139","BTC","BK4129","TRNR","ETH","BK4594","SNPX","BK4023","APT.USD.CC","SOL","BK4601","BK4190","BK4519","APT.USD.HKCC","ETH.USD.HKCC"],"gpt_icon":1},{"id":"2542016338","title":"BRIEF-Synaptogenix Says On June 8, Alan Tuchman Resigned As CEO And Director Of Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2542016338","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542016338?lang=en_us&edition=fundamental","pubTime":"2025-06-09 22:11","pubTimestamp":1749478272,"startTime":"0","endTime":"0","summary":"BRIEF-Synaptogenix Says On June 8, Alan Tuchman Resigned As CEO And Director Of CoJune 9 (Reuters) - Synaptogenix Inc SNPX.O:SYNAPTOGENIX INC: ON JUNE 8,  ALAN J. TUCHMAN RESIGNED AS CEO AND DIRECTOR ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nFWN3SA020:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNPX"],"gpt_icon":0},{"id":"2542938796","title":"Synaptogenix Inc: on June 8,  Alan J. Tuchman Resigned as CEO and Director of Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2542938796","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542938796?lang=en_us&edition=fundamental","pubTime":"2025-06-09 21:17","pubTimestamp":1749475076,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nFWN3SA020:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNPX","BK4139"],"gpt_icon":0},{"id":"2542638799","title":"Synaptogenix Inc: Tuchman to Serve as Chief Medical Officer of Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2542638799","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542638799?lang=en_us&edition=fundamental","pubTime":"2025-06-09 21:17","pubTimestamp":1749475076,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nFWN3SA020:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNPX","BK4139"],"gpt_icon":0},{"id":"2542387941","title":"Synaptogenix Inc: on June 6, Joshua Silverman Appointed as Executive Chairman of Co’s Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2542387941","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542387941?lang=en_us&edition=fundamental","pubTime":"2025-06-09 21:17","pubTimestamp":1749475076,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nFWN3SA020:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SNPX"],"gpt_icon":0},{"id":"2542931387","title":"Synaptogenix Inc - Series D Preferred Stock Conversion Price Set at $3.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2542931387","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542931387?lang=en_us&edition=fundamental","pubTime":"2025-06-09 21:14","pubTimestamp":1749474878,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nFWN3SA04Z:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNPX","BK4139"],"gpt_icon":0},{"id":"2542876813","title":"Synaptogenix Inc - Plans Initial $10 Mln Tao Acquisition, Targets $100 Mln in Tao Token Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2542876813","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542876813?lang=en_us&edition=fundamental","pubTime":"2025-06-09 21:14","pubTimestamp":1749474878,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nFWN3SA04Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNPX","BK4139"],"gpt_icon":0},{"id":"2542538768","title":"Synaptogenix: Launch of Differentiated Cryptocurrency Treasury Strategy Focused Exclusively on AI Crypto Token \"Tao\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2542538768","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542538768?lang=en_us&edition=fundamental","pubTime":"2025-06-09 21:14","pubTimestamp":1749474878,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nFWN3SA04Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNPX","BK4139"],"gpt_icon":0},{"id":"2542438793","title":"Synaptogenix Inc - Enters $5.5 Mln Financing Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2542438793","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542438793?lang=en_us&edition=fundamental","pubTime":"2025-06-09 21:14","pubTimestamp":1749474878,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nFWN3SA04Z:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SNPX"],"gpt_icon":0},{"id":"2542382056","title":"Synaptogenix Inc. Secures $5.5 Million in Equity Investment Through Sale of Series D Convertible Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2542382056","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542382056?lang=en_us&edition=fundamental","pubTime":"2025-06-09 21:00","pubTimestamp":1749474051,"startTime":"0","endTime":"0","summary":"Synaptogenix Inc. has announced a $5.5 million equity investment through securities purchase agreements involving the sale of 5,500 shares of its newly issued Series D convertible preferred stock. This preferred stock, with a stated value of $1,000 per share, is convertible into common stock and comes with five-year common stock purchase warrants, all set with a conversion and exercise price of $3.00 per share. Notably, prominent investor James Altucher is involved in this financing, which is expected to close around June 10, 2025, pending customary closing conditions. This investment aligns with Synaptogenix's strategy to bolster its digital asset treasury, focused on the AI token TAO.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sy","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDLhsp4t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNPX"],"gpt_icon":0},{"id":"2542382291","title":"Press Release: Synaptogenix Appoints Crypto Expert to Lead Digital Asset Treasury Strategy Focused Exclusively on Top-Valued AI Token","url":"https://stock-news.laohu8.com/highlight/detail?id=2542382291","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542382291?lang=en_us&edition=fundamental","pubTime":"2025-06-09 21:00","pubTimestamp":1749474000,"startTime":"0","endTime":"0","summary":"Singular focus on Bittensor , the leading AI token by. James Altucher to lead TAO token strategy initiatives. Planned initial acquisition of $10 million in TAO equates to over two times the Company's. Synaptogenix plans to acquire $10 million in TAO tokens initially, which amounts to over two times the Company's current market valuation. The Company's strategy is targeted to acquire $100 million of TAO tokens. The initial acquisition will be funded by the Company's significant cash reserves and well-capitalized balance sheet.\"Based on our initial review, we believe the fixed market supply of 21 million TAO tokens alongside rapidly increasing global demand for AI development and adaptation makes TAO a compelling cryptocurrency,\" Silverman concluded.\"The AI industry is expected to grow tenfold between now and 2030, and some percentage of every dollar allocated to AI is expected to go towards decentralized AI where TAO is the clear leader. I am excited to be a part of what I believe is th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TON.USD.CC","US7Y.BOND","US5Y.BOND","BK4596","APT.USD.CC","BTC.USD.HKCC","US3Y.BOND","STRK","US2Y.BOND","BK4023","SNPX","TON.USD.HKCC","BK4595","APT.USD.HKCC","BK4585","TAO","US6M.BOND","US12M.BOND","US30Y.BOND","BK4139","BK4600","BK4516","US10Y.BOND","BK4588","BTC.USD.CC"],"gpt_icon":1},{"id":"2535064768","title":"Synaptogenix Q1 EPS $0.04 Up From $(0.41) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2535064768","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535064768?lang=en_us&edition=fundamental","pubTime":"2025-05-16 05:52","pubTimestamp":1747345924,"startTime":"0","endTime":"0","summary":"Synaptogenix (NASDAQ:SNPX) reported quarterly earnings of $0.04 per share. This is a 109.76 percent increase over losses of $(0.41) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45456638/synaptogenix-q1-eps-0-04-up-from-0-41-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNPX"],"gpt_icon":0},{"id":"2530215933","title":"Psychedelic: Clearmind completes clinical site initiations for AUD trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2530215933","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530215933?lang=en_us&edition=fundamental","pubTime":"2025-04-25 23:30","pubTimestamp":1745595026,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on site initiations, dosing completion and clinical site partnerships.Discover outperforming stocks and invest smarter with Top Smart Score Stocks.Filter, analyze, and streamline your search for investment opportunities using  Tipranks' Stock Screener.“AUD remains one of the most urgent and underserved public health challenges globally,” said Dr. Adi Zuloff-Shani, CEO. “With millions affected and current treatments often falling short, the study initiation for our FDA-approved CMND-100 trial marks a critical step toward potentially transforming the treatment landscape for alcoholism. We are honored to collaborate with world renowned institutions such as Yale and Johns Hopkins as we advance our mission to potentially provide safe, effective, and innovative solutions for individuals those suffering from alcoholism.”“Completing dosing of all participants in Part A of our 005 tria","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-clearmind-completes-clinical-initiations-153026935.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-clearmind-completes-clinical-initiations-153026935.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4202","BETRF","AGNPF","DRUG","SILO","FLHLF","NRXP","ENTBF","PHRRF","SPRC","SEEL","BK4547","CMND","PBM","BK4168","BK4007","PSYGF","MNMD","ALID","OPTHF","ATAI","MYCOF","QNTM","SNPX","MDXXF","BK4139","MIRA","RVVTF","ENVB","CMPS","GHRS","IXHL","CYBN","BK4539","RLMD","KTTA","NUMIF"],"gpt_icon":0},{"id":"2521172612","title":"Psychedelic: Exclusive talk with biotech company Clearmind Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2521172612","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521172612?lang=en_us&edition=fundamental","pubTime":"2025-03-22 22:30","pubTimestamp":1742653811,"startTime":"0","endTime":"0","summary":"In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Mark Haden, vice president of business development at Clearmind Medicine , a psychedelic pharmaceutical biotech company focused on development of therapeutics to solve underserved health problems. Here are some highlights:. Discover stocks' market position with detailed  competitor analyses.“Think of this space as being two overlapping circles, a Venn diagram,” Haden said. “There are addiction treatments, like counseling, Alcoholics Anonymous and some pharmaceutical interventions like Antabuse, naltrexone and acamprosate. I ran an addictions treatment program for 28 years and I can assure you that there is relatively low efficacy, the dropout rate is high, and the treatments tend to be very long-term. That’s the first circle.”“You can take MEAI if you are addicted to alcohol and you don’t want to stop,” Haden said. “You can add MEAI to your alcohol and we believe it will result in people drinking less. It c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-exclusive-talk-biotech-company-143011967.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-exclusive-talk-biotech-company-143011967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4202","PBM","BK4547","NUMIF","MYCOF","BK4539","DRUG","ALID","BETRF","IXHL","PSYGF","NRXP","MDXXF","CYBN","KTTA","SEEL","RVVTF","FLHLF","SPRC","QNTM","BK4139","MNMD","BK4168","PHRRF","MIRA","SNPX","RLMD","SILO","CMND","ATAI","AGNPF","GHRS","BK4007","ENTBF","OPTHF","CMPS"],"gpt_icon":0},{"id":"2519638156","title":"Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2519638156","media":"TipRanks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519638156?lang=en_us&edition=fundamental","pubTime":"2025-03-14 23:40","pubTimestamp":1741966809,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on a dosing initiation, a development expansion and a distribution agreement.Discover stocks' market position with detailed  competitor analyses.MIRA EXPANDS KETAMIR-2 DEVELOPMENT WITH TOPICAL: On Thursday, MIRA Pharmaceuticals  announced the formulation of Ketamir-2 into a topical treatment for localized neuropathic and inflammatory pain. This expands the company’s pain management portfolio beyond its ongoing Ketamir-2 oral treatment for neuropathic pain, offering a novel, targeted approach for localized pain relief. The topical treatment of Ketamir-2 is designed for slow release, delivering targeted pain relief directly at the application site while minimizing systemic exposure and side effects.“The development of both an oral and topical formulation of Ketamir-2 significantly expands our pipeline and enhances the value proposition of MIRA,” stated Erez Aminov, CEO . “By adv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-atai-reports-dosing-first-154009720.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-atai-reports-dosing-first-154009720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4168","MYCOF","KTTA","QNTM","BK4139","FLHLF","SILO","SNPX","SPRC","BK4539","CMND","IXHL","MDXXF","ATAI","MIRA","BK4547","GHRS","CYBN","OPTHF","BK4202","SEEL","NUMIF","BK4007","NRXP","ALID","MNMD","PHRRF","BETRF","DRUG","AGNPF","ENVB","ENTBF","RVVTF","PBM","PSYGF","CMPS","RLMD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNPX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-04-05","symbol":"SNPX","defaultRemindTime":1712323800000,"type":"split","dateTimestamp":1712289600000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2021-05-19","symbol":"SNPX","defaultRemindTime":1621431000000,"type":"split","dateTimestamp":1621396800000,"forFactor":4,"toFactor":1,"ratio":4}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNPX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SNPX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SNPX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SNPX","date":"2025-06-20","current":-0.467963,"percent":0.745665,"low":-9.66416,"twenty":-2.728721,"median":-0.855541,"eighty":-0.440764,"high":-0.218238,"avg":-2.101841,"sd":2.552706,"marketCap":5698241},"quantilePoints":[{"date":"2024-01-05","current":-8.968923,"twenty":-8.968923,"median":-8.968923,"eighty":-8.968923,"marketCap":5024301},{"date":"2024-01-12","current":-9.573161,"twenty":-9.409361,"median":-9.118163,"eighty":-8.968923,"marketCap":5362789},{"date":"2024-01-19","current":-8.462964,"twenty":-9.47124,"median":-9.118163,"eighty":-8.852443,"marketCap":4740868},{"date":"2024-01-26","current":-7.374609,"twenty":-9.420281,"median":-8.881563,"eighty":-7.319281,"marketCap":4131182},{"date":"2024-02-02","current":-6.515573,"twenty":-9.199698,"median":-8.599463,"eighty":-7.09797,"marketCap":3649959},{"date":"2024-02-09","current":-7.203493,"twenty":-9.100691,"median":-7.461968,"eighty":-7.130002,"marketCap":4035325},{"date":"2024-02-16","current":-6.511933,"twenty":-8.992947,"median":-7.29089,"eighty":-6.958922,"marketCap":3647920},{"date":"2024-02-23","current":-6.817692,"twenty":-9.016971,"median":-7.29089,"eighty":-6.768188,"marketCap":3819203},{"date":"2024-03-01","current":-7.916967,"twenty":-8.916507,"median":-7.316369,"eighty":-6.784204,"marketCap":4435006},{"date":"2024-03-08","current":-6.679371,"twenty":-8.837883,"median":-7.25449,"eighty":-6.749259,"marketCap":3741717},{"date":"2024-03-15","current":-6.551972,"twenty":-8.765083,"median":-7.203493,"eighty":-6.628411,"marketCap":3670349},{"date":"2024-03-22","current":-7.06157,"twenty":-8.572164,"median":-7.187132,"eighty":-6.688108,"marketCap":3955821},{"date":"2024-03-28","current":-6.934171,"twenty":-8.279509,"median":-7.16349,"eighty":-6.685195,"marketCap":3884453},{"date":"2024-04-05","current":-0.611201,"twenty":-7.969383,"median":-7.13619,"eighty":-6.530133,"marketCap":3690739},{"date":"2024-04-12","current":-0.867223,"twenty":-7.908231,"median":-7.07977,"eighty":-6.492277,"marketCap":5236731},{"date":"2024-04-19","current":-0.837567,"twenty":-7.809223,"median":-6.999691,"eighty":-5.893754,"marketCap":5057651},{"date":"2024-04-26","current":-0.793172,"twenty":-7.593007,"median":-6.863191,"eighty":-0.875491,"marketCap":4789574},{"date":"2024-05-03","current":-0.855541,"twenty":-7.454688,"median":-6.817692,"eighty":-0.853384,"marketCap":5166185},{"date":"2024-05-10","current":-0.846554,"twenty":-7.422657,"median":-6.746711,"eighty":-0.845475,"marketCap":5111918},{"date":"2024-05-17","current":-1.175489,"twenty":-7.384437,"median":-6.693932,"eighty":-0.8433,"marketCap":5328985},{"date":"2024-05-24","current":-1.120425,"twenty":-7.365873,"median":-6.603442,"eighty":-0.845475,"marketCap":5079358},{"date":"2024-05-31","current":-1.062968,"twenty":-7.34549,"median":-6.515573,"eighty":-0.846554,"marketCap":4818878},{"date":"2024-06-07","current":-0.998328,"twenty":-7.316369,"median":-6.511933,"eighty":-0.846554,"marketCap":4525838},{"date":"2024-06-14","current":-1.188775,"twenty":-7.316369,"median":-6.369973,"eighty":-0.846554,"marketCap":5389215},{"date":"2024-06-21","current":-1.156131,"twenty":-7.275602,"median":-6.075135,"eighty":-0.850868,"marketCap":5241227},{"date":"2024-06-28","current":-1.115327,"twenty":-7.261042,"median":-5.772834,"eighty":-0.852665,"marketCap":5056243},{"date":"2024-07-05","current":-1.104445,"twenty":-7.243569,"median":-1.202376,"eighty":-0.855541,"marketCap":5006913},{"date":"2024-07-12","current":-1.186054,"twenty":-7.22901,"median":-1.194215,"eighty":-0.855541,"marketCap":5376882},{"date":"2024-07-15","current":-1.226859,"twenty":-7.224642,"median":-1.194215,"eighty":-0.856979,"marketCap":5561867},{"date":"2024-08-02","current":-1.099005,"twenty":-7.220274,"median":-1.194215,"eighty":-0.858417,"marketCap":4982249},{"date":"2024-08-09","current":-0.96571,"twenty":-7.205699,"median":-1.186054,"eighty":-0.864527,"marketCap":4377966},{"date":"2024-08-16","current":-2.678471,"twenty":-7.190404,"median":-1.1842,"eighty":-0.867583,"marketCap":4587615},{"date":"2024-08-23","current":-2.862241,"twenty":-7.164947,"median":-1.188775,"eighty":-0.87603,"marketCap":4902372},{"date":"2024-08-30","current":-2.70877,"twenty":-7.14893,"median":-1.198295,"eighty":-0.892199,"marketCap":4639510},{"date":"2024-09-06","current":-2.731791,"twenty":-7.137646,"median":-1.225499,"eighty":-0.901898,"marketCap":4678940},{"date":"2024-09-13","current":-2.186967,"twenty":-7.128546,"median":-2.186967,"eighty":-0.92176,"marketCap":3745780},{"date":"2024-09-20","current":-2.501583,"twenty":-7.09797,"median":-2.390316,"eighty":-0.949932,"marketCap":4284647},{"date":"2024-09-27","current":-2.409884,"twenty":-7.09069,"median":-2.386479,"eighty":-0.954828,"marketCap":4127587},{"date":"2024-10-04","current":-2.233009,"twenty":-7.05429,"median":-2.355785,"eighty":-0.96571,"marketCap":3824639},{"date":"2024-10-11","current":-2.270148,"twenty":-7.020074,"median":-2.317418,"eighty":-0.966323,"marketCap":3888251},{"date":"2024-10-18","current":-2.386479,"twenty":-6.986587,"median":-2.309744,"eighty":-0.969249,"marketCap":4087500},{"date":"2024-10-25","current":-2.409961,"twenty":-6.922523,"median":-2.355785,"eighty":-0.97115,"marketCap":4127718},{"date":"2024-10-31","current":-2.433776,"twenty":-6.875931,"median":-2.364227,"eighty":-0.97115,"marketCap":4168509},{"date":"2024-11-08","current":-2.437655,"twenty":-6.850451,"median":-2.360006,"eighty":-0.976591,"marketCap":4175152},{"date":"2024-11-15","current":-0.430537,"twenty":-6.824972,"median":-2.355785,"eighty":-0.97115,"marketCap":3538149},{"date":"2024-11-22","current":-0.423114,"twenty":-6.817692,"median":-2.3388,"eighty":-0.96571,"marketCap":3477147},{"date":"2024-11-29","current":-0.475405,"twenty":-6.811867,"median":-2.325092,"eighty":-0.911614,"marketCap":3906876},{"date":"2024-12-06","current":-0.488272,"twenty":-6.769643,"median":-2.302071,"eighty":-0.866324,"marketCap":4012614},{"date":"2024-12-13","current":-0.442084,"twenty":-6.739068,"median":-2.275213,"eighty":-0.850868,"marketCap":3633042},{"date":"2024-12-20","current":-0.423114,"twenty":-6.704852,"median":-2.263703,"eighty":-0.844271,"marketCap":3477147},{"date":"2024-12-27","current":-0.544357,"twenty":-6.695388,"median":-2.255696,"eighty":-0.836855,"marketCap":4473522},{"date":"2025-01-03","current":-0.583947,"twenty":-6.688108,"median":-2.225412,"eighty":-0.821391,"marketCap":4798870},{"date":"2025-01-10","current":-0.597143,"twenty":-6.674479,"median":-2.19464,"eighty":-0.812763,"marketCap":4907319},{"date":"2025-01-17","current":-0.544357,"twenty":-6.634324,"median":-1.709004,"eighty":-0.785551,"marketCap":4473522},{"date":"2025-01-24","current":-0.569101,"twenty":-6.551972,"median":-1.225499,"eighty":-0.641682,"marketCap":4676864},{"date":"2025-01-31","current":-0.552605,"twenty":-6.515573,"median":-1.194215,"eighty":-0.608707,"marketCap":4541303},{"date":"2025-02-07","current":-0.518789,"twenty":-6.515573,"median":-1.187415,"eighty":-0.583947,"marketCap":4263402},{"date":"2025-02-14","current":-0.478375,"twenty":-6.511933,"median":-1.183334,"eighty":-0.575699,"marketCap":3931277},{"date":"2025-02-21","current":-0.468477,"twenty":-6.511933,"median":-1.166795,"eighty":-0.566567,"marketCap":3849940},{"date":"2025-02-28","current":-0.460229,"twenty":-6.485725,"median":-1.156234,"eighty":-0.552275,"marketCap":3782160},{"date":"2025-03-07","current":-0.463116,"twenty":-6.391813,"median":-1.131648,"eighty":-0.544357,"marketCap":3805883},{"date":"2025-03-14","current":-0.478375,"twenty":-6.224374,"median":-1.119236,"eighty":-0.517634,"marketCap":3931277},{"date":"2025-03-21","current":-0.434298,"twenty":-6.097703,"median":-1.115327,"eighty":-0.506087,"marketCap":3569057},{"date":"2025-03-28","current":-0.440434,"twenty":-5.833294,"median":-1.104445,"eighty":-0.499489,"marketCap":3619486},{"date":"2025-04-04","current":-0.247082,"twenty":-3.583036,"median":-1.099005,"eighty":-0.489592,"marketCap":3154880},{"date":"2025-04-11","current":-0.233476,"twenty":-2.939882,"median":-1.084515,"eighty":-0.479694,"marketCap":2981153},{"date":"2025-04-17","current":-0.243272,"twenty":-2.899842,"median":-1.056982,"eighty":-0.478375,"marketCap":3106236},{"date":"2025-04-25","current":-0.250282,"twenty":-2.872984,"median":-1.030997,"eighty":-0.476207,"marketCap":3195740},{"date":"2025-05-02","current":-0.267763,"twenty":-2.857637,"median":-0.998328,"eighty":-0.472674,"marketCap":3418944},{"date":"2025-05-09","current":-0.261232,"twenty":-2.840755,"median":-0.976591,"eighty":-0.466897,"marketCap":3335556},{"date":"2025-05-16","current":-0.24164,"twenty":-2.803922,"median":-0.969962,"eighty":-0.461219,"marketCap":3085389},{"date":"2025-05-23","current":-0.252232,"twenty":-2.771693,"median":-0.96571,"eighty":-0.450474,"marketCap":3071352},{"date":"2025-05-30","current":-0.285344,"twenty":-2.759415,"median":-0.949388,"eighty":-0.447633,"marketCap":3474537},{"date":"2025-06-06","current":-0.30703,"twenty":-2.750207,"median":-0.893276,"eighty":-0.444394,"marketCap":3738602},{"date":"2025-06-13","current":-0.554708,"twenty":-2.738697,"median":-0.867223,"eighty":-0.441094,"marketCap":6754500},{"date":"2025-06-20","current":-0.467963,"twenty":-2.728721,"median":-0.855541,"eighty":-0.440764,"marketCap":5698241}],"updateTime":1750705274386}}}